KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Illumina (ILMN) Accumulated Expenses (2016 - 2025)

Illumina's Accumulated Expenses history spans 16 years, with the latest figure at $846.0 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 2.3% year-over-year to $846.0 million; the TTM value through Dec 2025 reached $846.0 million, up 2.3%, while the annual FY2025 figure was $846.0 million, 2.3% up from the prior year.
  • Accumulated Expenses reached $846.0 million in Q4 2025 per ILMN's latest filing, up from $746.0 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $1.4 billion in Q3 2022 to a low of $541.0 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $953.5 million, with a median of $827.0 million recorded in 2024.
  • Peak YoY movement for Accumulated Expenses: surged 100.89% in 2022, then crashed 42.34% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $666.0 million in 2021, then skyrocketed by 71.47% to $1.1 billion in 2022, then grew by 16.02% to $1.3 billion in 2023, then plummeted by 37.58% to $827.0 million in 2024, then grew by 2.3% to $846.0 million in 2025.
  • Per Business Quant, the three most recent readings for ILMN's Accumulated Expenses are $846.0 million (Q4 2025), $746.0 million (Q3 2025), and $762.0 million (Q2 2025).